Positive list system to cause industries and patients heavy burdens.

Published: 2006-08-08 07:00:00

Updated: 2006-08-08 07:00:00

The positive list system raises a controversial backlash in the pharmaceutical industry. After the government's advanced announcement of its legislation plan, the drug industry made a loud voice with slight different logics from the foreign multinational drug corporations operating in Korea, clai...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK